Ironwood Pharmaceuticals, Inc. - Class A Share Price
NASDAQ: IRWDHealthcare
Live Ironwood Pharmaceuticals, Inc. - Class A Share Price Chart
O H L
Ironwood Pharmaceuticals, Inc. - Class A Performance Overview
Days Range
▼
$4.19Low
$4.28High
Markets Today
| Previous Close | $4.23 |
|---|---|
| Open | $4.22 |
| Volume | 369,800 |
| Day's Range | $4.19 - $4.28 |
| 52W Range | $1.26 - $5.78 |
| Market Cap | $689.05 M |
Historical Performance
| 1M Returns | -1.86 |
|---|---|
| 3M Returns | +19.49 |
| 6M Returns | +33.44 |
| 1Y Returns | +189.73 |
| 5Y Returns | -65.75 |
| 10Y Returns | -71.59 |
Ironwood Pharmaceuticals, Inc. - Class A Fundamentals
| Market Cap | $689.05 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 5.50 |
| PEG Ratio | N/A |
| Revenue | $296.15 M |
| ROE TTM | N/A |
| EPS TTM | $0.76 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $120.64 M |
| Profit Margin | 8.11 |
| Market Cap | $689.05 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 5.50 |
| PEG Ratio | N/A |
| Revenue | $296.15 M |
| ROE TTM | N/A |
| EPS TTM | $0.76 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $120.64 M |
| Profit Margin | 8.11 |
Ironwood Pharmaceuticals, Inc. - Class A Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $41.14 M | $85.24 M | $122.06 M | $47.71 M | $106.51 M | $113.04 M |
| Gross Profit + | $41.14 M | $85.24 M | $122.06 M | $47.71 M | $106.51 M | $113.04 M |
| Operating Income | -$29.11 M | $45.32 M | $75.48 M | $6.80 M | $72.57 M | $79.31 M |
| EBITDA | -$10.07 M | $45.54 M | $78.16 M | $7.01 M | $72.98 M | $79.76 M |
| Interest Expense | -$8.07 M | -$8.36 M | -$8.43 M | -$7.89 M | -$9.14 M | -$7.20 M |
| Depreciation | $19.04 M | $217.00 K | $2.67 M | $208.00 K | $403.00 K | $457.00 K |
| Income Before Tax | -$36.27 M | $37.82 M | $68.02 M | $455.00 K | $65.17 M | $73.73 M |
| Income Tax Expense | $1.11 M | $14.22 M | $27.94 M | $2.73 M | $24.40 M | $22.44 M |
| Net Income + | -$37.39 M | $23.60 M | $40.08 M | -$2.28 M | $40.77 M | $51.29 M |
| Net Profit Margin | -90.87% | 27.69% | 32.84% | -4.77% | 38.28% | 45.37% |
Ironwood Pharmaceuticals, Inc. - Class A Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $162.00 K | $162.00 K | $163.00 K | $163.00 K | $165.00 K | $165.00 K |
| Reserve & Surplus | -$1.73 B | -$1.71 B | -$1.67 B | -$1.67 B | -$1.63 B | -$1.58 B |
| Non-Current Liabilities | $613.17 M | $418.58 M | $417.72 M | $416.52 M | $415.40 M | $414.12 M |
| Current Liabilities | $48.10 M | $232.53 M | $242.50 M | $242.22 M | $236.31 M | $32.85 M |
| Total Liabilities | $661.27 M | $651.11 M | $660.22 M | $658.74 M | $651.71 M | $446.97 M |
| Fixed Assets | $6.91 M | $6.38 M | $5.91 M | $5.45 M | $5.00 M | $4.55 M |
| Current Assets | $160.58 M | $191.75 M | $273.84 M | $274.18 M | $332.29 M | $199.20 M |
| Total Assets | $327.21 M | $342.95 M | $396.06 M | $396.90 M | $434.57 M | $285.13 M |
Ironwood Pharmaceuticals, Inc. - Class A Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$37.39 M | $23.60 M | $40.08 M | -$2.28 M | $40.77 M | $51.29 M |
| Operating Cash Flow | $19.95 M | -$15.07 M | $47.58 M | $74.58 M | $5.12 M | $58.28 M |
| Investing Cash Flow | -$31.00 K | -$2.00 K | -$2.00 K | $1.00 K | $0 | $0 |
| Financing Cash Flow | $6.00 K | $88.00 K | $0 | $122.00 K | $0 | -$199.70 M |
| Change in Cash | $19.92 M | -$15.63 M | $47.55 M | $75.05 M | $5.01 M | -$141.34 M |
Ironwood Pharmaceuticals, Inc. - Class A Peer Comparison
| Company | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|
 | $463.89B | 145.08% | 74.25 | 6.92% | 2.64% |
Ironwood Pharmaceuticals, Inc. - Class A Return Calculator
The Ironwood Pharmaceuticals, Inc. - Class A stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$3,449
Invested Amount$10,000
Est. Returns$-6,551
About Ironwood Pharmaceuticals, Inc. - Class A
Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.
Popular Stocks
FAQs
What is the share price of Ironwood Pharmaceuticals, Inc. - Class A today?
Ironwood Pharmaceuticals, Inc. - Class A (IRWD) share price as of September 18, 2026 is $4.26. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Ironwood Pharmaceuticals, Inc. - Class A?
Yes, Indian Investors can invest in the Ironwood Pharmaceuticals, Inc. - Class A (IRWD) Share by opening an international trading account with Angel One.
How can I purchase Ironwood Pharmaceuticals, Inc. - Class A shares in India?
Purchasing Ironwood Pharmaceuticals, Inc. - Class A (IRWD) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Ironwood Pharmaceuticals, Inc. - Class A (IRWD) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Ironwood Pharmaceuticals, Inc. - Class A?
Yes, you can purchase fractional shares of Ironwood Pharmaceuticals, Inc. - Class A (IRWD) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Ironwood Pharmaceuticals, Inc. - Class A?
The market capitalization of Ironwood Pharmaceuticals, Inc. - Class A on September 18, 2026, is $689.05 M.
In which sector Ironwood Pharmaceuticals, Inc. - Class A belongs?
Ironwood Pharmaceuticals, Inc. - Class A operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Ironwood Pharmaceuticals, Inc. - Class A stocks?
In order to invest in Ironwood Pharmaceuticals, Inc. - Class A (IRWD) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
